Amyris, Inc. [NASDAQ: AMRS] declared that it has commenced the proposed underwritten public offering of shares of its common stock. It has disclosed that is carrying a resale of its stock on behalf of its existing shareholders. The selling shareholders are DSM International B.V. and affiliates of Vivo Capital LLC.
The selling stockholders are planning to propose a total of $150.0 million of shares of Amyris’s common stock. Moreover, AMRS is also planning to propose $100.0 million of shares of its common stock in order to assist its continuing development.
Benefit for Underwriters
Amyris has revealed that it has decided to offer the underwriters a 30-day choice to buy up to an extra $37.5 million of shares of common stock of Amyris at the public offering price, deducting underwriting markdowns and expenses. The offer of the firm is dependent on certain markets and other circumstances. The firm has not guaranteed the exact closure date of the offering.
Furthermore, Amyris has not declared the real size and terms of the suggested offering. The joint book-running manager for the offering is Cowen and Company, LLC, and J.P. Morgan Securities LLC. Additionally, AMRS disclosed that it will not get any profit from the sale of offering by the selling shareholders.